Subscribe

Spotlight -

Brad Rovin, MD

Articles by Brad Rovin, MD

Kidney Compass: Obinutuzumab, REGENCY, & Updates in Lupus Nephritis, With Brad Rovin, MD

Kidney Compass: Obinutuzumab, REGENCY, & Updates in Lupus Nephritis, With Brad Rovin, MD

ByShikha Wadhwani, MD, MS,Brad Rovin, MD

November 8th 2025

Discover groundbreaking insights on lupus nephritis treatment from the REGENCY trial, highlighting the impact of obintuzumab on patient outcomes.

Latest Updated Articles

Kidney Compass: Obinutuzumab, REGENCY, & Updates in Lupus Nephritis, With Brad Rovin, MD
November 8th 2025

Trending on Rheumatology Live

Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More

Risankizumab’s Durable Efficacy, Safety in PsA, With Frank Behrens, MD